Results 91 to 100 of about 23,381 (306)

Endodontic therapy and Medication-related osteonecrosis of the jaw onset: a scoping review and expert opinion-based qualitative meta-synthesis

BMC Oral Health
Introduction Medication-related osteonecrosis of the Jaw (MRONJ) is a serious side effect of bone-modifying agents (BMAs), including bisphosphonates, denosumab, and antiangiogenic drugs.
R. Mauceri, M. Coppini, V. C. A. Caponio, F. Zamparini, C. Prati, G. Campisi   +5 more
doaj   +1 more source

Maxillary osteonecrosis linked to Pembrolizumab therapy: a case report

Journal of Oral Medicine and Oral Surgery
Introduction: Osteonecrosis of the jaw is a serious condition often associated with the use of bone-modifying agents or antiangiogenics. Recent evidence suggests that immune checkpoint inhibitors, including Pembrolizumab, might also contribute to ...
Gosselin-Rousselle Louise, Gaudimier Zoé, Pamelard Pierre-Olivier, Sader Paul, Moizan Hervé   +4 more
doaj   +1 more source

Exploring Perimenopausal and Menopausal Women's Oral Health Perceptions and Practices in Australia—A Qualitative Study

Gerodontology, EarlyView.
ABSTRACT Objective To explore the perceptions and practices of women in peri/menopause towards oral healthcare in Australia. Background Hormonal changes associated with peri/menopause create a period where women may be more prone to developing oral health problems, which can significantly impact their quality of life.
Namitha Thomas, Kath Peters, Kate O' Reilly, Mariana S. Sousa, Ajesh George   +4 more
wiley   +1 more source

Bisphosphonate-related osteonecrosis of the jaws (Bronj) [PDF]

, 2013
Bisphosphonate-related osteonecrosis of the jaws (BRONJ) is an extremely therapy resistant osteomyelitis-like disease exclusively involving the jaw bones of patients in treatment with bisphosphonates (BPs).
Beninatio, Francesco, Ficarra, Giuseppe, Pruneti, Riccardo   +2 more
core   +1 more source

Recommendations for bone‐directed therapy in patients with neuroendocrine tumour skeletal metastases at the New Zealand National Neuroendocrine Tumour Multidisciplinary Meeting

Internal Medicine Journal, EarlyView.
Abstract The role of anti‐resorptive agents in patients with bone metastases from neuroendocrine neoplasms is unclear. Our aim was to review bone‐specific treatment recommendations by the New Zealand National Neuroendocrine Tumour Multidisciplinary Meeting (MDM).
Gayle Radley, Marianne S Elston, Ben Lawrence, Veronica Boyle   +3 more
wiley   +1 more source

[Basic Studies on the Mechanism, Prevention, and Treatment of Osteonecrosis of the Jaw Induced by Bisphosphonates].

Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan, 2020
Since the first report in 2003, bisphosphonate-related osteonecrosis of the jaw (BRONJ) has been increasing, without effective clinical strategies.
Y. Endo, H. Funayama, K. Yamaguchi, Y. Monma, Zhiqian Yu, Xue Deng, T. Oizumi, Y. Shikama, Yukinori Tanaka, S. Okada, Siyoung Kim, Tomomi Kiyama, K. Bando, K. Shima, Hikari Suzuki, Tetsu Takahashi   +15 more
semanticscholar   +1 more source

Bone metabolism and clinical study of 44 patients with bisphosphonate-related osteonecrosis of the jaws [PDF]

, 2012
Osteonecrosis of the jaws is a clinical entity described and linked to treatment with bisphosphonates in 2003. Its real incidence is unknown and it could increase due to the large number of patients treated with these drugs, and its cumulative effect on ...
Bocanegra Pérez, Sacramento, Limiñana Cañal, José María, López Márquez, Ariadna, Pérez Plasencia, D., Ramos Macías, Ángel, Rodríguez Bocanegra, Eduardo, Sosa Henríquez, Manuel, Vicente Barrero, Mario   +7 more
core   +1 more source

Bisphosphonate-Related Osteonecrosis of the Jaw Mimicking Bone Metastasis

Case Reports in Oncological Medicine, 2014
Osteonecrosis of the jaw is usually a potential complication of bisphosphonate therapy. In a cancer patient, this disease entity can be misdiagnosed as a metastatic lesion. Our aim is to make clinicians aware of bisphosphonate associated osteonecrosis of
Geetika Bhatt, Aashish Bhatt, Anthony E. Dragun, Xiao-Feng Li, A. Cahid Civelek   +4 more
doaj   +1 more source

Experience with the treatment of bisphosphonate-related osteonecrosis of the jaw

Biomedical Papers, 2015
Aim: This article covers the authors' experience with the treatment of bisphosphonate-related osteonecrosis of the jaw in 11 individuals. Methods: A retrospective study of patients diagnosed and treated for bisphosphonate-related osteonecrosis of the jaw
Zuzana Janovska, Radovan Mottl, Radovan Slezak   +2 more
doaj   +1 more source

Trend Analysis of Medically Related Osteonecrosis of the Jaw in the United States Using US National Inpatient Data From 2016 to 2022

Journal of Public Health Dentistry, EarlyView.
ABSTRACT Objectives This study presents a trend analysis of Medication‐Related Osteonecrosis of the Jaw (MRONJ) using US National Inpatient Sample (NIS) data from 2016 to 2022, providing insights into its epidemiology, comorbidities, and economics.
N. Sheshashayee, M. B. Rao, E. Holmes, D. G. Krishnan   +3 more
wiley   +1 more source